Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Bob, very strong, but totally inaccurte comments. Please stick to the point and discuss the TRXX opportunity.
As stated, the board of directors is as published. If you want the answer form a third party, please call the company and they will tell you themselves.
Even if you are right and the board of Directors are only "advisers" to the company, then if as you say this is scam, why would named experieneced MD's publicly put their name to anything or advise it, unless all MD's are involved and support scams?
It would be a bit like someone recommending an IBM platform when they neither worked for IMB or new nothing about IBM platforms. It wouldn't happen as you would check them out before you let them near your system, right. So if you doubt this, check them out, call the company, call the MD's and put your mind to rest.
POD
Good find and you're right, COBE is part og the Gambro Group.
The cobe equipment is for the stem cell collection which is a pretty straight forward proceedure. Bit like taking blood and dialysis. Most equipment in the medical field is based on old or existing equipment. I will have a look and see if they are using an upated COBE product, but I am sure that all equipment, however old, has to comply to the latest medicl standards in any case.
Useful info, thanks.
Lem, good morning.
All valid and good points made, but you make the assumption that only specific indidivuals were hurt. This is not the case. Pink sheets are a lottery and only once in a while a real opportunity arises, and I truly belive Stem Cell assurance is.
To correct a few points, the companies you mentioned are still in existance to one degree or another and were all development stage companies needing finance t the time we invested.
To be specific, the technology developed for the little hand held device is currently in use in the NHS in the management of dementia patients who are cared for at home. It is used to manage and monitor cross speciality care, the reason the technology was developed. The RFID technology is still in play with the Rexam but again if you refer to the business plan, the sales cycle was 18 months to 2 years, hence why I believe we have had this chnge of focus and the obvious link up.
The only thing that is important is the share holder value which on pink sheets is direclty attributable to the pps and liquidity, and then the subsequent move to a higher board if the business justifies it. This is directly attributable to revenue.
So as you say, the shell lives on. If that is the case, doesn't that unquestionable fact give every share holder the chance to be a part of a success, to have the chnace to profit and to win. Isn't that why we are all on iHub and why we all invest.
So siomply, if the shell as you put it is still alive, then at least the shareholders have a chance and from my perspective, having a chance to win on a stock is better than not having a chnce at all. Wouldn't you agree?
POD
Bob, Good DD.
In order for this to be a factual DD statemnt, you need to cover all the salient points. You have missed out the section that states wihtin the medical profession, it is expected that any and all MD's will have cases and suits recorded against them over the course of their career purely based on the fact that, and excuse the humor, their job is "hands" on with ptients. As you know, there are individuls in this world who will publicly cry wolf and make allegtions that are unfounded. This is more prevelant in the healthcare arena becuase the MD's deal with sick and ill poeple with high expectations of their MD everyday.
I would suggest you check out your own hopsital Doctor and see if he has any cases against him. I am sure he has and I am sure they were unfounded which is why he probably is still practicing. But he will still have the case recorded against his medical and career record. It's normal full disclosure.
POD
GM, TRXX Board and managemnt team.
Sorry bob missed your question yesterday.
The board and management team has been published and I believe discussed previoulsy.
The President Gloria McConnell is listed on Pink Sheets. From my perspective, it is pretty obvious who the bord is (published) and that this is a real company with real poeple. Below is the managemnt team and Directors. If you still doubt the validity of the company and the bord, the easy way to address this would be to call the company or any of the MD's named, (561-362-4142), and ask them who the board is and are they real. That way you will get your answer direclty from the company.
When you have done so, please share with the rest of us so we can put this particular issue you have to bed. If anyone else wants to do this then we can have two independent sources of confirmation.
Dr. Richard Ferrans - M.D. - Chairman, Dr. Vikki Hufnagel - M.D. - Medical Director Gloria McConnell - President, Dr. Kurk Wagner - M.D. - Medical Advisory Board, Dr. Leonard Haimes - M.D. - Medical Advisory Board, Dr. Glenn Charles - D.O. - Medical Advisory Board, Richard Proodian - CFO and Vice President of Finance, George Dubec - Vice President of Marketing, Mandy Clark - Vice President of Operations.
POD
TRXX Stem Cell have updated the web site
www.stemcellassurance.com
TRXX Stem Cell Business Plan Published in the Pink Sheets April 17th
http://www.pinksheets.com/otciq/ajax/showFinancialReportById.pdf?id=20775
POX
I concur and about time we got down to the real issue, Stem Cell assurance.
Welcome BEE.
A couple of questiosn that have been posted are based on where are the stem cells held, how are they held. The answers to all these questions are in the published business plan. So for the first center, they are colected and stored cryogenically at Dr Haimes' center. The detials of the type or storage and collection process are also contined wihtin the business plan.
From what I see, the board is made up of those listed on the first press release and it looks to me that all those MD's listed, will also open centers. So the management team and board are buying and creating there own company.
Fianlly what impresses me is that if you read the business plan, the total years target is for 455 stem cell colelction appointments ($1.5M). That IMO is not a large target especially when they have committed to 5 centers. The first on day one did 3 appointments so if they keep that up it would be around 500 stem cell collections per year from one center.
That's why this compnay excites me and that's why there is so much buzz around stem cell treatments.
POD
My sentiments exaclty and good points made. All I hope is that news comes out, it is positive and we, the investors, win.
Good Point Bob, there is no news from the company at the moment, except the e-mail statement from the CEO.
My guess is your either right or wrong and only news will deal with that but so long as this stock keeps positve, who the hell cares, as the investors, like you, will profit if they hold stock and sell as it moves up. Works for me. Interesting to see how this plays out.
GLTY.
TRXX defintley in the right market
Don't know what the world's coming to since the EO went out they're all at it!
"Following the sale of $6.85 billion in bonds -- including $5.2 billion in Recovery Act-backed bonds -- California Gov. Arnold Schwarzenegger said more than 5,000 projects will be restarted in California.
The funding will be allocated as follows:
* $1.7 billion for the state’s taxable general obligation bonds to fund stem cell research and stem cell related projects, various housing programs, and additional needs for High Speed Rail."
Great Pick BB. love the sotck and love the Autstrians!
Hey, 3000% TRXX gain is nothing compared to what it might achieve. Ever since the NIH changed the rules last week the money has been pouring into this market through grants and the Pharmaceutical Industry.
Another one today:
New York Stem Cell Foundation Receives Grant for Diabetes Research from Helmsley Foundation
http://www.pharmalive.com/News/index.cfm?articleid=620514&categoryid=15
GM. Even the Chinese are into stem cell storage.
China Breaks Ground on Largest Comprehensive Stem Cell Storage and Processing Facility
http://news.prnewswire.com/DisplayReleaseContent.aspx?ACCT=104&STORY=/www/story/04-22-2009/0005010651&EDATE=
Hi Bob. No traxxec is not the only company that makes them. I was answering a question on the link between RFID tags, used on plastic packaging FDA approved, and Stem cells. Stem cells, IMO, being a degrading entity if not properly stored cryogenically, are kept in plastic bags which is the ideal medium for RFID tags which Traxxec manufacture through a license with Rexam Plc. I was purely surmising that is probably a sensible link.
But at the end of the day, 2000% + increase in share holder value and a real market emerging, as a shareholder, you as I, should be pleased.
TRXX/Stem Cell Board - Dr. Richard Ferrans - M.D. - Chairman
Dr. Vikki Huffnagel - M.D. - Medical Director
Dr. Kurk Wagner - M.D. - Medical Advisory Board
Dr. Leonard Haimes - M.D. - Medical Advisory Board
Dr. Glenn Charles - D.O. - Medical Advisory Board
Richard Proodian - CFO and Vice President of Finance
Gloria McConnell - President
George Dubec - Vice President of Marketing
Mandy Clark - Vice President of Operations
TRXX may have pulled off a massive deal. Hufnagel - massive name in medicine and a lot of publications. Also check out the video.
No problem. If you take a look at the Stem Cell Assurnace web site and watch the video, they show you a blood bag so you can actually see the potential of using RFID.
http://www.stemcellassurance.com/
I think you called TRXX 100% right, have you seen the website and who's behind the company?
http://www.stemcellassurance.com/
All bloods, including stem cells, are stored in palstic bags/containers. The safest and most secure current method of recording and labelling any product, especially anything cryogenically frozen, is RFID.
Hope that helps.
By LINDA A. JOHNSON – 19 hours ago
TRENTON, N.J. (AP) —
The report predicts mergers and acquisitions will grow in the next few quarters in the stem-cell arena, following President Obama's executive order allowing use of federal funding for embryonic stem-cell research.
Venture capitalists and large drugmakers seeking to boost their stem-cell research capabilities are likely to invest in the field, according to the report. One potential target for big drugmakers is International Stem Cells Corp., which is doing early-stage testing of treatments using stem cells.
Copyright © 2009 The Associated Press. All rights reserved.
Full Article
http://www.stemcelldigest.net/stemcell/stem-cell-company-market-.html
GMTA.
A lot of useful information about the Stem Cell market in this link. Here's to another good day for all.
http://www.stemcelldigest.net/stemcell/stem-cell-company-market-.html
Hi Bob, glad to see you're still alive and well.
No pumping from me - 3 posts - 3 references that's it, and just a little humour. Just quoting the facts. Check my posts.
If investors with knwoledge and insight decide any stock is worth investing in, then that's up to them isn't it? It's not for me or you to decide.
What surprises me is that no one picked the reorg up. Hope you're still holding and make some money.
GLTY
This market has everything - leading edge and models - maybe I should get my girlfrined to invest!
http://www.scienceandsupermodels.com/2009/04/18/stem-cells-get-practical-liposuction-and-breast-enhancement-all-at-once/
Stem cell is everywhere. Just Google it
http://www.edmontonsun.com/News/Canada/2009/04/16/9139396.html
100% not rumours. TRXX made the statement that they are reorganising.
They have and they have moved into the stem cell business. If you look at the releases from Obama, there is real money from the Government and the Phamaceutical Industry going into this. You just have to know where to look.
POD
GM. You will remember that TRXX stated at the end of last year they were undertaking a reorganization. They have and they are staying in the Medical space but moving into Stem Cell technology and treatments.
Here's an indication on the level of investment that goes into these deals.
http://www.upi.com/Science_News/2009/04/15/Gore-backs-stem-cell-venture/UPI-35461239768975/
Happy reading.
POD
TRXX has life after all!
Not sure if anyone's around on this board, looks pretty quiet.
Anyways, have crashed and burned on Pinkies more times than I care to remember, took some time out and played with other ex's. But I remembered one of the founders told me that once in a while, after all the losers, you will find one Pinky that may have a chance to be the real deal.
Well IMHO, this is the one and if you look hard enough, the info is there in the PD, hope you've been watching. So any idiot holding from the beginning, like me, has a real chance to profit on this stock.
If anyone's out there happy to share, if not, GLTYA.
POD
Nice, and how you doing?
Been in this a long time so glad Conrad is getting his stuff together, always belived this was a winner and not on the Pinks!
Don't know if anyone has read the disclosure but there are several interesting things that are hinted at:
Clothing and Fashion shows - hints at high end of the market and that the product is there.
New Continents - We know UK, Europe, Australia and Asia are in the bag but there is also mention on UAE, US and the only other realsitic continent left is Africa. That makes 6 major rallies a year at $600,000 per rally. Remember running costs covered by the entrants.
He mentions target annual earnings of $2.4m and advance set up costs already covered not including merchandising.
Power boat series - more reveune and more merchandising.
And so it goes on. Just think if he went into Franchsing the Brand!!!!
POD.
CRVR
3.3m in float, trading c100K moving average and building strong base which is rising every day. Traded 25% of the flaot in last week mving it's position up nicely. With momentum IMHO this will pop in a big way.
POD
Just in case there are any CRVR followers out there, some good background to the market.
POD
One quarter of the major pharmaceutical players in the US will implement large-scale radio frequency identification (RFID) technology projects with the aim of cutting costs, improving inventory control, keeping tabs on clinical trials and managing the distribution of samples. Kalorama Information, a leading publisher of market research in biotechnology medical markets, forecasts a dramatic growth surge in the US market for radio frequency identification (RFID) technology in pharmaceutical manufacturing and distribution over the next five years. The medical market research firm sees a compound annual growth rate of 59.6 per cent for the US market in 2007-2012, taking revenues up from $58m last year to $600m five years down the line.
The Kalorma report notes that “Radiofrequency identification is positioned to be a top solution in manufacturing and distribution, clinical trials and sample distribution.” A 2003 industry study by Accenture had pointed out that the new RFID technology could save the packaged goods, retail and freight transportation industries billions of dollars each year.
In the United States, the RFID market had been bolstered by the Food and Drug Administration, the Department of Defense, and major retailers like WalMart and Target, all who have placed RFID requirements on its suppliers. The DoD requires all 50,000 of its suppliers to track supplies with RFID. The FDA has specifically recognized RFID as the technology best suited to providing track-and-trace and pedigree for pharmaceutical products in the supply chain, requiring drug distributors to provide full traceability throughout the drug supply chain. The federal agency also promotes RFID as the best technology to combat counterfeit drugs.
More and more organizations are turning to RFID for a wide variety of requirements. The technology has demonstrated widespread civil use in such areas as mass transit payment terminals, electronic toll collections, animal control and identification, public and school and university libraries, prisons, people tracking, passports, product tracking and inventory control. Innovative uses continually arise. Kazakhstan and Lithuanian customs officials are using electronic seals to ensure truck cargo doors are not opened en route. Hong Kong and Las Vegas airports are upgrading and ramping up their RFID bag-tagging efforts. Sam’s Club, owned and operated by Wal-Mart, as of Jan. 31, 2008 began requiring all of its suppliers to apply electronic product codes (EPC) Gen 2 RFID tags to every full single-item pallet of goods destined for its distribution center in DeSoto, Texas, or directly to one of its stores served by that DC.
“[T]he day will come when RFID tags are not applied like a label, but are integrated into the material of packaging….The benefits to that is that it will cost less than sticking a label on, and that there is less risk that tags will be damaged, plus, there would be no delay in packaging line speed.”
A technology called chipless RFID allows for discrete identification of tags without an integrated circuit, making it possible for tags to be printed directly onto assets or bottles at a lower cost than that required for the traditional two part antenna and integrated circuit chip procedure. Eight years ago Traxxec’s auto-ID system was acknowledged by the industry as the best auto-Id system commercially available. After two successful pilot implementations in partnership with major multi-national companies, Traxxec developed, patented, and commercialized a fully integrated RFID High Density Polyethylene (HDPE) product as its first product based on the tagged bottle concept. By printing RFID tags at the unit level on bottles, Traxxec’s tagged bottle concept not only provided a solution to an un-met need, it also had the effect of accelerating the rate at which RFID is adopted by the market. Incorporated specifically to exploit this IP commercially, Traxxec Ltd has also supplied commercial product for a live, current phase III study in the US.
The substantial data and experience Traxxec’s founders have accumulated in the industry underlines the Company’s goal to be recognized as a leader in innovation and integration of auto-id technologies in supply chain and packaging solutions. Traxxec’s industry recognized experience allows it to deliver technology consultancy services based on its core competency of systems design and integration to a select customer base that includes its licenses, on a fee for service basis. The Company has recently announced confirmation of last years 15-year license contracted to Rexam Pharma, a world leading supplier of pharma packaging. Traxxec will receive royalties on sales made and support Rexam’s manufacturing excellence with support in the area of sales, marketing, implementation and cost justification analysis. As part of the technology transfer to Rexam Pharma, commercial product was successfully manufactured by them and supported by systems software provided by Traxxec Ltd. To date 21,000 units have been delivered. Thanks to the encapsulation and the integration of the RFID tag in the bottle, the RFID enabled container from Rexam Pharma stands out against the solutions currently available on the market.
Course of Development
The key focus for the Company’s immediate development will be efficiency and volume of new and existing routes to market. Product development has obtained IP protection and manufacturing out-licensed by agreement has been established and successfully conducted as the sales strategy. The negotiated policy agreement with Rexam PLC allows Traxxec to sell directly into the pharmaceutical clinical trial arena and to pharmaceutical contract and clinical research organizations. Further, Columbia River Resources Inc. will be filing to change the corporate name to Traxxec Inc. as the completion of its reorganization.
Assisting Traxxec with product development are two commercial arrangements it has with Assa Abloy identification Technologies, a Swiss-based global leader in the supply of packaged RFID component parts, and with Telsonic Ultrasonics, specializing in the economical assemblage of thermoplastic components.
Expanding RFID Market Penetration
Traxxec Ltd reported on Apr 16, 2008 negotiations to supply Glaxo SmithKline and Catalent with RFID procedures and methods through its new clinical trials sales division. Catalent and Glaxo SmithKline are two of the biggest suppliers in the contract and pharma arena. In addition, the Company is also negotiating for same with a French-based global leader in the beauty Industry. All three companies are interested in evaluating the effectiveness of RFID in their supply chain.
CEO Amy Scopes commented, “These new sales channels represent a specialist sector of our business expansion plan and revenue generation. We believe our previous strong performance in this arena will be of significant benefit in the expansion of this sector.”
Well, they keep trying for you! This is good background info. Hope it works out for all of us.
POD
One quarter of the major pharmaceutical players in the US will implement large-scale radio frequency identification (RFID) technology projects with the aim of cutting costs, improving inventory control, keeping tabs on clinical trials and managing the distribution of samples. Kalorama Information, a leading publisher of market research in biotechnology medical markets, forecasts a dramatic growth surge in the US market for radio frequency identification (RFID) technology in pharmaceutical manufacturing and distribution over the next five years. The medical market research firm sees a compound annual growth rate of 59.6 per cent for the US market in 2007-2012, taking revenues up from $58m last year to $600m five years down the line.
The Kalorma report notes that “Radiofrequency identification is positioned to be a top solution in manufacturing and distribution, clinical trials and sample distribution.” A 2003 industry study by Accenture had pointed out that the new RFID technology could save the packaged goods, retail and freight transportation industries billions of dollars each year.
In the United States, the RFID market had been bolstered by the Food and Drug Administration, the Department of Defense, and major retailers like WalMart and Target, all who have placed RFID requirements on its suppliers. The DoD requires all 50,000 of its suppliers to track supplies with RFID. The FDA has specifically recognized RFID as the technology best suited to providing track-and-trace and pedigree for pharmaceutical products in the supply chain, requiring drug distributors to provide full traceability throughout the drug supply chain. The federal agency also promotes RFID as the best technology to combat counterfeit drugs.
More and more organizations are turning to RFID for a wide variety of requirements. The technology has demonstrated widespread civil use in such areas as mass transit payment terminals, electronic toll collections, animal control and identification, public and school and university libraries, prisons, people tracking, passports, product tracking and inventory control. Innovative uses continually arise. Kazakhstan and Lithuanian customs officials are using electronic seals to ensure truck cargo doors are not opened en route. Hong Kong and Las Vegas airports are upgrading and ramping up their RFID bag-tagging efforts. Sam’s Club, owned and operated by Wal-Mart, as of Jan. 31, 2008 began requiring all of its suppliers to apply electronic product codes (EPC) Gen 2 RFID tags to every full single-item pallet of goods destined for its distribution center in DeSoto, Texas, or directly to one of its stores served by that DC.
“[T]he day will come when RFID tags are not applied like a label, but are integrated into the material of packaging….The benefits to that is that it will cost less than sticking a label on, and that there is less risk that tags will be damaged, plus, there would be no delay in packaging line speed.”
A technology called chipless RFID allows for discrete identification of tags without an integrated circuit, making it possible for tags to be printed directly onto assets or bottles at a lower cost than that required for the traditional two part antenna and integrated circuit chip procedure. Eight years ago Traxxec’s auto-ID system was acknowledged by the industry as the best auto-Id system commercially available. After two successful pilot implementations in partnership with major multi-national companies, Traxxec developed, patented, and commercialized a fully integrated RFID High Density Polyethylene (HDPE) product as its first product based on the tagged bottle concept. By printing RFID tags at the unit level on bottles, Traxxec’s tagged bottle concept not only provided a solution to an un-met need, it also had the effect of accelerating the rate at which RFID is adopted by the market. Incorporated specifically to exploit this IP commercially, Traxxec Ltd has also supplied commercial product for a live, current phase III study in the US.
The substantial data and experience Traxxec’s founders have accumulated in the industry underlines the Company’s goal to be recognized as a leader in innovation and integration of auto-id technologies in supply chain and packaging solutions. Traxxec’s industry recognized experience allows it to deliver technology consultancy services based on its core competency of systems design and integration to a select customer base that includes its licenses, on a fee for service basis. The Company has recently announced confirmation of last years 15-year license contracted to Rexam Pharma, a world leading supplier of pharma packaging. Traxxec will receive royalties on sales made and support Rexam’s manufacturing excellence with support in the area of sales, marketing, implementation and cost justification analysis. As part of the technology transfer to Rexam Pharma, commercial product was successfully manufactured by them and supported by systems software provided by Traxxec Ltd. To date 21,000 units have been delivered. Thanks to the encapsulation and the integration of the RFID tag in the bottle, the RFID enabled container from Rexam Pharma stands out against the solutions currently available on the market.
Course of Development
The key focus for the Company’s immediate development will be efficiency and volume of new and existing routes to market. Product development has obtained IP protection and manufacturing out-licensed by agreement has been established and successfully conducted as the sales strategy. The negotiated policy agreement with Rexam PLC allows Traxxec to sell directly into the pharmaceutical clinical trial arena and to pharmaceutical contract and clinical research organizations. Further, Columbia River Resources Inc. will be filing to change the corporate name to Traxxec Inc. as the completion of its reorganization.
Assisting Traxxec with product development are two commercial arrangements it has with Assa Abloy identification Technologies, a Swiss-based global leader in the supply of packaged RFID component parts, and with Telsonic Ultrasonics, specializing in the economical assemblage of thermoplastic components.
Expanding RFID Market Penetration
Traxxec Ltd reported on Apr 16, 2008 negotiations to supply Glaxo SmithKline and Catalent with RFID procedures and methods through its new clinical trials sales division. Catalent and Glaxo SmithKline are two of the biggest suppliers in the contract and pharma arena. In addition, the Company is also negotiating for same with a French-based global leader in the beauty Industry. All three companies are interested in evaluating the effectiveness of RFID in their supply chain.
CEO Amy Scopes commented, “These new sales channels represent a specialist sector of our business expansion plan and revenue generation. We believe our previous strong performance in this arena will be of significant benefit in the expansion of this sector.”
Absolutely but as you say if it works....
Good luck to you too.
Columbia River Resources Inc. (OTC: CRVR), through its recently acquired subsidiary, Traxxec Ltd., specializes in the development of auto-ID and Radio Frequency Identification (RFID) and their supportive systems and applications in pharma packaging and auto-identification technologies.
Major pharmaceutical companies in the US are positioning for large-scale radio frequency identification (RFID) technology projects with the aim of cutting costs, keeping tabs on clinical trials, improving inventory control, and managing the distribution of samples. Kalorama Information, a leading publisher of market research in biotechnology medical markets, forecasts a dramatic growth surge in the US market for radio frequency identification (RFID) technology in pharmaceutical manufacturing and distribution over the next five years. The medical market research firm sees a compound annual growth rate of 59.6 per cent for the US market in 2007-2012, taking revenues up from $58m last year to $600m five years down the line.
RFID technology has demonstrated widespread and growing use in such areas as electronic toll collections, mass transit payment terminals, animal control and identification, public and school and university libraries, passports, and enterprise supply chain management consisting of product tracking and inventory control. Sam’s Club, owned and operated by Wal-Mart, on Jan. 31, 2008 began requiring all of its suppliers to apply electronic product codes (EPC) Gen 2 RFID tags to every full single-item pallet of goods destined for its distribution center in DeSoto, Texas, or directly to one of its stores served by that DC. Innovative uses continually arise. Nestlé Italy is expanding a pilot program employing RFID tags with built-in temperature sensors to track ice cream moving from production factories to distribution centers and on to retail stores. Aircraft manufacturer Airbus has recently adapted from trials RFID applications TO track the locations of the large metal frames, known as jigs, that it uses to transport large aircraft sections.
The RFID market had been bolstered by proactive support from the FDA, the Department of Defense, and major retailers like WalMart and Target who along with the DoD have placed RFID requirements on their suppliers. The FDA has specifically recognized RFID as the technology best suited for anti-counterfeiting measure in today’s pharmaceutical market and to providing track-and-trace and pedigree for pharmaceutical products in the supply chain. The DoD is pressing for all 50,000 of its suppliers to be RFID compliant.
A report from The Healthcare Distribution Management Association issued late last year identified annual savings up to $1 Billion for drug manufacturers using RFID technology and EPC, with distributors obtaining up to $400 million annually in economic benefits due to improved due to inventory management efficiency and counterfeit prevention.
Traxxec developed an auto-ID system based on chipless RFID technology eight years ago that was acknowledged by the industry as the best auto-Id system then commercially available. Chipless RFID is a technology that allows for discrete identification of tags without an integrated circuit, enabling tags to be printed directly onto assets or bottles at a lower cost than that required for the traditional two part antenna and integrated circuit chip procedure.
After two successful pilot implementations in partnership with major multi-national companies, Traxxec developed, patented, and commercialized a fully integrated RFID High Density Polyethylene (HDPE) product as its first tagged bottle product. By printing RFID tags at the unit level on bottles. Traxxec’s tagged bottle not only provides a solution to an un-met need, it also has the effect of accelerating the rate at which RFID is adopted by the market.
Incorporated specifically to exploit this IP commercially, Traxxec Ltd supplied commercial product for a live, current phase III study in the US.
Traxxec’s founders have built strong relationships in both the global pharmaceutical industry and Radio Frequency Identification (RFID) component sectors for over 20 years. The company’s small, focused management team has developed considerable expertise in providing packaging solutions and innovative products in a variety of industries. Traxxec’s goal is to be recognized as a leader in innovation and integration of auto-id technologies in supply chain and packaging solutions. The substantial data and experience its founders have accumulated in the industry affords it a core competency of systems design and integration, enabling performance as technology consultancy delivered to a select customer base on a fee for service basis, backed by its patented licenses.
The Company has recently announced confirmation of last years 15-year license contract with Rexam Pharma, a world leading supplier of pharma packaging. Rexam has integrated an RFID tag into its comprehensive range of pill jars with tamper evident and child resistant closures. Traxxec will receive royalties on sales made and support Rexam’s manufacturing excellence with support in the area of sales, marketing, implementation and cost justification analysis. As part of the technology transfer to Rexam Pharma, commercial product was successfully manufactured by them and supported by systems software provided by Traxxec Ltd. To date 21,000 units have been delivered. Thanks to the encapsulation and the integration of the RFID tag in the bottle, the RFID enabled container from Rexam Pharma stands out against the solutions currently available on the market.
There is a lot of awareness and DD out there now through StockGuru and several sites so might as well share it.
For one, any stock that has the potential to make money is worth the effort. So for those that haven't seen the DD, and for any new poeple thought I would psot it all. Hope it does us some good for anyone watching.
POD
StockGuru Trade Alert: Columbia River Resources (CRVR) has Solid Bid Support and is Breaking Out
Today’s Current Volume of 181,987 is Already Up More than 67% from the Ten-Day Average of 108,587!
Columbia River Resources Inc. (OTC:CRVR), through its recently acquired subsidiary, Traxxec Ltd., specializes in the development of auto-identification technologies and Radio Frequency Identification (RFID) products and their supportive systems.
One quarter of the major pharmaceutical players in the US will implement large-scale radio frequency identification (RFID) technology projects with the aim of cutting costs, improving inventory control, keeping tabs on clinical trials and managing the distribution of samples. Kalorama Information, a leading publisher of market research in biotechnology medical markets, forecasts a dramatic growth surge in the US market for radio frequency identification (RFID) technology in pharmaceutical manufacturing and distribution over the next five years. The medical market research firm sees a compound annual growth rate of 59.6 per cent for the US market in 2007-2012, taking revenues up from $58m last year to $600m five years down the line.
The Kalorma report notes that “Radio frequency identification is positioned to be a top solution in manufacturing and distribution, clinical trials and sample distribution.” A 2003 industry study by Accenture had pointed out that the new RFID technology could save the packaged goods, retail and freight transportation industries billions of dollars each year.
In the United States, the RFID market had been bolstered by the Food and Drug Administration, the Department of Defense, and major retailers like WalMart and Target, all who have placed RFID requirements on its suppliers. The DoD requires all 50,000 of its suppliers to track supplies with RFID. The FDA has specifically recognized RFID as the technology best suited to providing track-and-trace and pedigree for pharmaceutical products in the supply chain, requiring drug distributors to provide full traceability throughout the drug supply chain. The federal agency also promotes RFID as the best technology to combat counterfeit drugs.
More and more organizations are turning to RFID for a wide variety of requirements. The technology has demonstrated widespread civil use in such areas as mass transit payment terminals, electronic toll collections, animal control and identification, public and school and university libraries, prisons, people tracking, passports, product tracking and inventory control. Innovative uses continually arise. Kazakhstan and Lithuanian customs officials are using electronic seals to ensure truck cargo doors are not opened en route. Hong Kong and Las Vegas airports are upgrading and ramping up their RFID bag-tagging efforts. Sam’s Club, owned and operated by Wal-Mart, as of Jan. 31, 2008 began requiring all of its suppliers to apply electronic product codes (EPC) Gen 2 RFID tags to every full single-item pallet of goods destined for its distribution center in DeSoto, Texas, or directly to one of its stores served by that DC.
“[T]he day will come when RFID tags are not applied like a label, but are integrated into the material of packaging….The benefits to that is that it will cost less than sticking a label on, and that there is less risk that tags will be damaged, plus, there would be no delay in packaging line speed.”
A technology called chipless RFID allows for discrete identification of tags without an integrated circuit, making it possible for tags to be printed directly onto assets or bottles at a lower cost than that required for the traditional two part antenna and integrated circuit chip procedure. Eight years ago Traxxec’s auto-ID system was acknowledged by the industry as the best auto-Id system commercially available. After two successful pilot implementations in partnership with major multi-national companies, Traxxec developed, patented, and commercialized a fully integrated RFID High Density Polyethylene (HDPE) product as its first product based on the tagged bottle concept. By printing RFID tags at the unit level on bottles, Traxxec’s tagged bottle concept not only provided a solution to an un-met need, it also had the effect of accelerating the rate at which RFID is adopted by the market. Incorporated specifically to exploit this IP commercially, Traxxec Ltd has also supplied commercial product for a live, current phase III study in the US.
The substantial data and experience Traxxec’s founders have accumulated in the industry underlines the Company’s goal to be recognized as a leader in innovation and integration of auto-id technologies in supply chain and packaging solutions. Traxxec’s industry recognized experience allows it to deliver technology consultancy services based on its core competency of systems design and integration to a select customer base that includes its licenses, on a fee for service basis. The Company has recently announced confirmation of last years 15-year license contracted to Rexam Pharma, a world leading supplier of pharma packaging. Traxxec will receive royalties on sales made and support Rexam’s manufacturing excellence with support in the area of sales, marketing, implementation and cost justification analysis. As part of the technology transfer to Rexam Pharma, commercial product was successfully manufactured by them and supported by systems software provided by Traxxec Ltd. To date 21,000 units have been delivered. Thanks to the encapsulation and the integration of the RFID tag in the bottle, the RFID enabled container from Rexam Pharma stands out against the solutions currently available on the market.
Course of Development
The key focus for the Company’s immediate development will be efficiency and volume of new and existing routes to market. Product development has obtained IP protection and manufacturing out-licensed by agreement has been established and successfully conducted as the sales strategy. The negotiated policy agreement with Rexam PLC allows Traxxec to sell directly into the pharmaceutical clinical trial arena and to pharmaceutical contract and clinical research organizations. Further, Columbia River Resources Inc. will be filing to change the corporate name to Traxxec Inc. as the completion of its reorganization.
Assisting Traxxec with product development are two commercial arrangements it has with Assa Abloy identification Technologies, a Swiss-based global leader in the supply of packaged RFID component parts, and with Telsonic Ultrasonics, specializing in the economical assemblage of thermoplastic components.
Expanding RFID Market Penetration
Traxxec Ltd reported on Apr 16, 2008 negotiations to supply Glaxo SmithKline and Catalent with RFID procedures and methods through its new clinical trials sales division. Catalent and Glaxo SmithKline are two of the biggest suppliers in the contract and pharma arena. In addition, the Company is also negotiating for same with a French-based global leader in the beauty Industry. All three companies are interested in evaluating the effectiveness of RFID in their supply chain.
CEO Amy Scopes commented, “These new sales channels represent a specialist sector of our business expansion plan and revenue generation. We believe our previous strong performance in this arena will be of significant benefit in the expansion of this sector.”
Thanks for the response appreciate it and will tread carefully. But I do think with such a tight float it has as good a chance as any.
Be lucky and thnaks,
POD.
Hi, been reading some of your posts and your philopshy on trsidng and positng is a good one.
Would be interested in your veiws on CRVR.
3.3m in the float
1m traded over the last 10 days
Upward momentum
15 year licence deal with Rexam
They did a reverse last months so most of the stock around is $3 plus to make any profit. Figures calculate only 200K shares around belwo $1
Big profile covered by stockguru.com
I'm in but would like to share some thoughts with others about whether this could be a big winner based on the market pressures? With interest coming in, and all DD stacks up this would blow into the $$s.
POD.
OT:CRVR.
Not sure if anyone's aware of this stock but it has been buildng momentum lately. Only 3.3m in flaot and big chunck of that traded up in the past week. Ave Vol c100K, 3 days green in a row clsed 14/20. 15 year licnece deakl with Rexam PLC.
Any thoughts would be welcomed. All DD copied below to save time for anyone interested.
POD.
Columbia River Resources Inc.
Columbia River Resources Inc. (OTC: CRVR), through its wholly owned subsidiary Traxxec Ltd, is a specialist in providing packaging solutions, in particular in relation to auto-id and Radio Frequency Identification (RFID), where it holds intellectual property and considerable practical experience and knowledge.
The company’s small, focused management team has considerable expertise in providing packaging solutions and developing innovative products in a variety of industries, including pharmaceuticals, where the founders have more than 20 years experience. Strong relationships have been developed in both the global pharmaceutical industry and RFID component sectors over a period of many years.
Manufacturing and Service Industries worldwide are on the cusp of a RFID transformation. Retailers, manufacturers, aerospace, defence, pharmaceutical and healthcare companies have found competitive advantage by intelligently moving the technology forward in to the business strategy playing field
The founders recognised the benefits of the application of RFID technology to the pharmaceutical industry sector more than eight years ago which, when presented to the industry, was acknowledged as the best Auto-Id system commercially available. They subsequently demonstrated the potential with two successful pilot implementations in partnership with major multi-national companies. Following on from these pilots a project report was commissioned by a major pharmaceutical company to identify the issues affecting the practical application of RFID technology. The report’s findings highlighted the weaknesses of the current methods of tag application to packaging items and, as a consequence, the management team set out to develop, patent and commercialise fully integrated RFID enabled packing products.
The first such product – a HDPE pharmaceutical grade bottle – has been produced, its intellectual property protected by a patent and has already been sold to clients in the UK and USA.
Traxxec is in collaboration with Rexam Pharma through a 15 year license contract completed on April 14th 2007. Rexam Pharma is a leading supplier of packaging globally - www.rexam.com. Rexam will supply a range of Radio Frequency enabled products under this license - developed in line with recent guidelines from the Food and Drugs Administration - and Traxxec will receive royalties on sales made and support Rexam’s manufacturing excellence with support in the area of sales, marketing, implementation and cost justification analysis. Traxxec is also able to make available to potential customers the substantial data that has resulted from the founders work in this arena over a period of many years. The license contract was signed by all parties on April 24th 2007 and marketing has begun through Rexam.
Development Background
• 1998: the application of RFID was first presented to the pharmaceutical industry
• 1999: installed two successful pilot implementations in the UK for evaluation purposes
• 2001: the application received international recognition at the Barcelona Conference. In his summing-up the conference chairman, Dr Andreas Fischer of PriceWaterhouse Coopers Consulting, made the following statement;
"In our experience every single pharmaceutical company has identified clinical supply as a critical area for immediate process re-design. At the very least companies are establishing formal quarterly meetings between supply planners and clinical to have a view of likely demand over the next six months. At the other extreme companies are looking at ways of implementing modern supply chain concepts such as MRP II and JIT with associated IT support. We have seen at this conference an example of a technology which will be used to better manage inventory throughout the supply chain"
• 2004:
o feasibility study carried out for GlaxoSmithKline
o FDA directive on RFID
FDA released guidelines for the implementation of RFID as the major technology to combat counterfeit drugs.
"The adoption and common use of reliable track and trace technology is feasible in 2007, and would help secure the integrity of the drug supply chain by providing an accurate drug "pedigree," which is a secure record documenting the drug was manufactured and distributed under safe and secure conditions………….Radio frequency Identification (RFID) tagging of products by manufacturers, wholesalers, and retailers appears to be the most promising approach to reliable product tracking and tracing.
COMBATING COUNTERFEIT DRUGS A Report of the Food and Drug Administration, Feb 2004 (Extract)
The second significant development was the move by Wal-Mart to require all of its suppliers to provide RFID tags at the unit level. (RFID Guidelines and Requirements for CII Pharmaceuticals)
"We have a strong belief that RFID (radio frequency identification) will transform the supply chain for both Wal-Mart/SAM’S and our suppliers. Due to that belief, Wal-Mart/SAM’S has stated our expectation to have our Pharmacy Class 2 Narcotic Suppliers utilize RFID on all products no later than March 2004. Your successful participation will spearhead our effort to fully leverage the benefits of RFID.
• 2005:
o Commercial product development concluded
o Patent application made
o First commercial product supplied
o Started license negotiations with Rexam
• 2006:
o Letter of Intent with Rexam
o First US order placed and delivered
o Traxxec Ltd incorporated to hold the Intellectual Property and to facilitate the out-licensing of its IP
• 2007: License agreement entered in to with Rexam
• 2008: Acquisition by Columbia River Resources Inc
Columbia River Resources Inc. (OTC: CRVR)
Columbia River Resources Inc. (OTC: CRVR) - Thursday’s shares increased 25% to $0.15. The volume was 271,171. Traxxec Ltd, the U.K. subsidiary of Columbia River Resources Inc. , reported April 21st negotiations to supply Glaxo SmithKline and Catalent through its new clinical trials sales division. As reported last week, the company has negotiated a policy with Rexam plc that allows it to sell directly in to the pharmaceutical clinical trial arena and to pharmaceutical contract and clinical research organisations.Catalent and Glaxo SmithKline represent two of the biggest names in the contract and pharma arena, ideal customers for the new division. In addition, Traxxec is in talks with a French-based global leader in the beauty Industry. All three companies are interested in evaluating the effectiveness of RFID in their supply chain. Such early positive results underline the importance of the new sales channels in addition to the 15-year licensing agreement currently in place with Rexam.
Columbia River Resources Inc., through its wholly owned subsidiary Traxxec Ltd, is a specialist in providing packaging solutions, in particular in relation to auto-id and Radio Frequency Identification (RFID), where it holds intellectual property and considerable practical experience and knowledge. The company’s small, focused management team has considerable expertise in providing packaging solutions and developing innovative products in a variety of industries, including pharmaceuticals, where the founders have more than 20 years experience. Strong relationships have been developed in both the global pharmaceutical industry and RFID component sectors over a period of many years. Manufacturing and Service Industries worldwide are on the cusp of a RFID transformation. Retailers, manufacturers, aerospace, defence, pharmaceutical and healthcare companies have found competitive advantage by intelligently moving the technology forward in to the business strategy playing field.
You guys shoud be on stage!
If you DD the recent trading then virtually all the float has been traded up. It think it is light 200K shares below $1 and the rest will only be sold above $3 unless investors want to get out at a loss.
Maybe it is down to the awareness that is probabaly building with StockGuru.
Eitherway it looks good to me.
POD